-
and curious Postdoctoral Fellow to develop and drive projects on retinal disease modeling and repair. OPTI is a part of Genentech Research and Early Development (gRED): scientists in gRED
-
Ciferri, VP of Protein Sciences, and in collaboration with the Bioconjugation and Delivery Lab led by Dr. Stephanie Monson. This group is responsible for the design and generation of new medicines
-
Fellow will lead projects that will advance our understanding on the role of distinct cellular states and tumor microenvironments in cancer, with a particular emphasis on metastatic breast cancer and tumor
-
research project as evidenced by a first author paper published or accepted in a leading peer-reviewed journal. You must have advanced technical training, as evidenced by a top method-focused conference
-
basis of Age-related macular degeneration. While this position is primarily computational, the project is highly collaborative, with regular interactions across laboratory, clinical and computational
-
. The postdoctoral fellow will initiate a research project to investigate interactions between commensal bacteria and/or pathogens and the host intestinal or respiratory mucosa at the molecular level. The successful
-
the Sterne-Weiler Lab i n Computational Biology / Discovery Oncology and co-mentored by the Frey Lab in Prescient Design (Machine Learning for Drug Discovery). The postdoctoral position is focused
-
and interdisciplinary group with diverse areas and commitment to tackle challenging problems in biology and medicine and will work on independent research projects, which leveraging collaborations
-
at Genentech. The Deshpande lab aims to answer fundamental mechanistic questions in cell death and inflammation using state-of-the-art protein science. Projects include identification and mechanistic